Arthritis and Musculoskeletal Alliance
Influencing policy and care together for best lifelong musculoskeletal health
CEO update by Sue Brown, ARMA
The general election is now in full swing. In amongst the Brexit debate, the NHS has been getting quite a bit of attention, albeit somewhat narrow in focus. I hope that after the election, whoever is in government, this debate will widen so that we can talk about health, not just the NHS, about more than hospitals, doctors and nurses.
One other thing an election brings is restrictions on what government bodies are allowed to do.…
Read more of this article
Public Health England has published the Productive Healthy Ageing Profile data update for November 2019.
This tool provides data on a wide range of topics relevant to healthy ageing. Indicators can be examined at local, regional or national level.
The aim of this tool is to support PHE productive healthy ageing policy and inform public health leads and the wider public health system about relevant key issues.
Many indicators are also now available for the latest local authority and clinical commissioning group geographies.
Dates for the next Versus Arthritis MSK Champion programme are now live on their website!
Following the successful launch of Versus Arthritis’s Musculoskeletal Champions programme in 2018, they’re recruiting the third cohort of inspirational leaders committed to championing change in musculoskeletal (MSK) health care.
If your application to this programme is successful, you will be coached to develop your personal leadership skills, and drive forward a service improvement project with an MSK focus.
Applications open from 30 March 2020.
Find out more here.
NICE guideline: Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal
The final scope and equality impact assessment for this NICE guideline have now been published, along with all the stakeholder comments that were received during consultation and our responses to these comments.
NICE identified ARMA as a stakeholder for this topic and ARMA is able to comment on the draft guideline when it is available. Please contact us should you have an interest in this topic and are a member.…
Read more of this article
Workplace health: long-term sickness absence and capability to work
NICE published this final guideline on the NICE website. You can also find the supporting evidence, tools and resources as well as all the stakeholder comments NICE received during consultation and the responses to these comments.
The recommendations from this guideline have been included in the NICE Pathway on Managing long-term sickness absence and capability to work, which brings together everything NICE said on Workplace health: long-term sickness absence and capability to work in an interactive flowchart.…
Read more of this article
Medical Devices Regulation from 2020On 26 May 2017 the Medical Devices Regulation (MDR 2017/745) was published, with the aim of replacing the current Medical Devices Directive (MDD 93/43/EC). Following a transition period of three years, this regulation will be applied in full from 26 May 2020.
The BOA has recently published its position statement on the MDR. They welcome the drive to improve the rigour and regulation of novel devices and procedures for the benefit of patients. However, the BOA raises some particular concerns with regard to legacy devices, regulation of different types of device, value of registry data in evaluating devices and long term monitoring.…
Read more of this article
Can you help us improve healthcare for people with fibromyalgia in the UK?
Professor Gary Macfarlane and Dr Rosemary Hollick of the PACFiND study team are looking for healthcare professionals who see patients with fibromyalgia to take part in a short online survey.
This survey will help PACFiND understand current provision of NHS services for people with fibromyalgia.
PACFiND (PAtient-centred Care for Fibromyalgia: New pathway Design) is a project aimed at developing new pathways of care for people with fibromyalgia.
Please click here to complete this survey.…
Read more of this article
Draft Scope Consultation
The National Institute for Health and Care Excellence (NICE) has been asked to consider an appraisal of guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs ID1658.
NICE invited organisations to take part in the consultation to discuss the draft remit and scope. The organisations selected as stakeholders are listed here and the draft scope that is being consulted on can be found here.
The consultation closes on Wednesday 18 December 2019. If you have any queries regarding this scoping exercise or would like to be involved you can contact Michelle Adhemar, Scoping Project Manager at scopingta@nice.org.uk…
Read more of this article
by Jenny Brodie, Senior Communications & Brand Officer, NASS
Today (01/11/2019) we re-launch our charity as the National Axial Spondyloarthritis Society.
For 43 years the NASS has supported people affected by ankylosing spondylitis. Rheumatologists can now diagnose people using MRI before the disease causes bone changes so treatment can start a lot earlier. They now use the term axial spondyloarthritis (axial SpA), which includes ankylosing spondylitis (AS).
This summer our members voted unanimously in favour of changing our name to reflect these changes.…
Read more of this article
Guest blog by Dr Alison Giles, Associate Director for Healthy Ageing, Centre for Ageing Better and Public Health England; and Elaine Rashbrook, Consultant Specialist, Life Course, Public Health England.
In October this year, Public Health England (PHE), together with the Centre for Ageing Better (CfAB) launched the Consensus Statement on Healthy Ageing. Over 70 organisations, including ARMA, have signed up and pledged to take action on the five principles set out in the Statement.
The average age at which people report a health condition or disability that interferes with daily life is just 62. …
Read more of this article
